Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines

Table 7

Average percent activity of positive control (SLS).

Concentration in percentage	Average percent activity of positive control (SLS)
	Hep-G2	A549	MCF-7	Jurkat	K562
5.000	100.092	100.309	99.305	91.243	109.321
2.500	99.610	100.247	98.861	99.553	106.180
1.250	99.037	101.210	98.764	106.009	116.717
0.625	98.716	100.370	99.459	105.433	120.770
0.313	98.097	100.111	99.768	100.000	104.762